click enter text
invest biz
invest summari report result morn
market open came slightli better expect littl
addit detail around pend merger aetna provid
compani use cash benefit associ tax chang
invest back busi reduc leverag net invest
lower profit growth algorithm note
embark somewhat unchart path remak
consum health experi merg aetna balanc great
manag team valuat well-below averag potenti loss
health care plan client possibl amazon entranc industri
remain peer perform rate equiti
quarter review morn report adj ep
compar street estim net sale ebit ex-
item approx forecast reduc
outlook adj oper profit growth driven larg part increment
invest fell today under-perform
outlook stand-alone estim ep
move respect
valuat trade ntm consensu ep well-below
long-term histor averag calendar year-end fair valu
estim low repres approx pro forma adj
ep reflect acquisit aetna valuat
well-below long-term averag believ risk profil around
increas driven subdu growth stand-alone compani
uncertainti around potenti growth profil merg compani
note ep estim pro forma announc acquisit aetna
trade fundament data
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
slightli outperform broader market far far calendar year
slightli better declin calendar equiti fell
compar rise calendar fell vs rise
trade ntm consensu ep compani averag
respect ev/ebitda basi trade
averag respect
calendar year-end fair valu estim low repres approxim pro
forma adj ep reflect announc acquisit aetna continu believ
use price-to-earnings multipl discount compani long-term price-to-earnings averag appropri given number
factor includ slow-down growth potenti amazon enter pharmaceut
dispens market believ ultim occur potenti attrit exist pbm
busi light merger aetna uncertainti around cvs/aet consum health
experi entail growth profil combin busi time
previous also reli dcf analysi reflect intrins valu stand-alone basi
given announc merger aetna place emphasi pro forma earn analysi valu
share better pictur emerg long-term cash flow potenti pro forma merg
risk peer perform rate
risk upsid
equiti valuat histor averag inde equiti trade well-below
long-term histor averag coupl dcf valuat stand-alone basi suggest
intrins valu well-abov equiti price posit news potenti translat higher equiti
price
win larg pbm contract similar downsid risk present loss larg pbm client
flipsid situat win larg pbm client could lead higher sale earn equiti price
strong manag team focus return organ stronger
growth team proven mani year strong steward busi
increasingli challeng landscap also return signific capit sharehold time
busi see challeng rebuild period sort believ team work
hard re-acceler growth compani abl sooner stronger fashion could lead
sale earn upsid rel current forecast potenti higher equiti price
page
produc signific cash flow focus enhanc sharehold return
multi-year period produc signific oper free cash flow help enterpris fund
grow dividend sizabl share repurchas annual believ compani oper model like
continu allow manag team return larg amount capit sharehold year
continu focus sharehold return next year like aberr return
capit sharehold due aetna acquisit suspens share repurchas program
lower leverag achiev howev busi perform expect would anticip
compani return capit sharehold may current anticip
announc acquisit aetna lead stronger growth profit combin basi
merger lead increas top-line growth less-than-anticip pbm client friction well stronger
profit part higher synergi could lead stronger earn higher valuat
thu higher equiti price time
risk downsid
growth profit outlook pro forma /aet enterpris lower-than-anticip
stand-alone compani also experienc subdu oper perform late particularli
pbm oper time embark path remak consum health experi
conjunct announc acquisit aetna remak experi take longer-than-anticip
could lead lower revenu earn growth synergi combin organ
lower-than-anticip need reinvest meaning busi could also
pressur oper result final pbm see more-than-anticip attrit client base and/or
amazon enter industri scenario would like hurt result
diminish compani vertic model advantag last competitor teamed-
offer similar program offer like mainten choic part result lose
script retail pharmaci segment reaction allow retail platform bring pbm
healthcar plan certain program exclus caremark pbm competitor continu
success mimic vertic model and/or decis let retail pharmaci busi partner
compani result signific loss caremark competit stand could detriment
revenu growth profit time major pbm oper particularli
script attempt carv retail pharmaci network could quit detriment earn
increas government involv healthcar industri long-term believ
encroach govern healthcar industri remain largest risk ultim form
govern control would government-sponsor system idea float time time
certain constitu washington appear countri move toward single-payor
system even slowli direct public option could weigh valuat
need mani servic could wane time scenario would note
manag strongli believ much outlier event
page
amazon enter prescript drug dispens market believ amazon enter market
next year inde case believ entranc amazon industri
would neg impact retail oper pbm busi caremark time believ
amazon would infrastructur fulfil recur acut script technolog interfac
mimic mani store program seem potenti expos issu
concern broader retail pharmaci industri doesnt happen take longer-than-than anticip
occur would like posit equiti
market share volum gain particularli health plan client materi
chang healthcar landscap health care plan play larger role marketplac
lower enterpris share health plan client rel employ client unabl increas
share script volum processed/dispens own asset health plan client could lead
subdu growth compani come year
enterpris profit growth less-than-anticip combin reimburs pressur busi
mix less increment benefit sourc gener like place pressur compani profit
margin near/medium-term vertic model time help mitig variou industri
headwind headwind becom greater-than-anticip profit could lower-than-expect
industri becom competit consum retail landscap pbm industri
remain competit action industri particip drive increas traffic retail drugstor
greater promot exampl attempt captur addit pbm client util price-driven strategi
could impact sale profit addit believ like entranc amazon
industri would real threat well broader retail pharmaci industri
increas reimburs pressur lower reimburs rate continu place downward
pressur profit margin reimburs pressur increas current anticip
could place even pressur profit increas govern involv long-
term could exacerb margin pressur govern program account approxim
reimburs govern predisposit put pressur profit healthcar industri
broadli could see acceler deterior reimburs rate time
unexpect loss larg pbm contract health pbm busi maintain high client
retent rate howev unexpect loss larg pbm client would like pressur sale profit
compani
page
earn driver outlook
revis stand-alone forecast follow compani fourth quarter earn result
ep estim move
respect first quarter rais store sale forecast pharmaci
front-end also improv profit margin forecast retail/ltc segment forecast
slight oper margin contract signific contract previous pharmaci servic segment
continu forecast low singl digit net sale growth incorpor modestli expens
pressur net chang lead higher earn balanc year maintain
store sale forecast retail/ltc segment increas expens pressur given
compani plan invest busi pharmaci servic segment balanc year
maintain net sale growth margin outlook pleas see model detail
forecast lower forecast stand-alone basi reflect reduc outlook well
addit cost associ compani invest pleas see pro forma cvs/aet
analysi model better reflect potenti pro forma earn includ transaction-rel
adjust impact relat merg compani
page
earn outlook tabl segment retail pharmaci consolid pharmaci consolid gross interseg segment total ebit consolid retail pharmaci consolid pharmaci interest expens interseg consolid gross incom net incom attribut ex retail pharmaci adj net incom cont op attribut ex pharmaci segment dilut ep attribut ex adj ep cont op attribut ex retail pharmaci pharmaci gener corpor weight average dilut share interseg ebit growth rate consolid gross retail pharmaci store ebit adj net incom cont op attribut ex adj ep cont op attribut ex pharmaci claim processedmail margin consolid retail pharmaci gross sg ebit average revenu mail retail pharmaci chang marginavg revenu gross sg ebit tax
highlight thought earn call
given aetna merger health care plan client base pbm remain concern
confer call manag note didnt see lot opportun gain addit health care
plan busi current pbm sell season one risk cvs/aet transact mind
potenti attrit caremark signific health care plan book busi becom vertic
integr aetna competitor similar concern around unit optum mostli
unfound stage continu believ natur friction/attrit take place
mergers/acquisit happen could greater given much busi come health care
plan move away outright lose busi could case merg
caremark need discount current custom keep fold
amazon loom larg retail pharmaci industri indic note
mind question amazon enter challeng retail busi
amazon decid enter market would like take signific market share opinion
prescript drug gener mani low cost interest see amazon
believ need pharmaci benefit manag partner
quarter review
morn market open report result adj ep slightli
ahead street estim consolid basi net sale approxim
forecast driven better top-line retail/ltc segment better top-line
pharmaci servic segment consolid ebit ex-item approxim
forecast retail/ltc segment oper profit came approxim forecast
pharmaci servic segment approxim gener corpor expens
interseg elimin forecast retail/ltc segment store sale
better estim pharmaci comp better estim
front-end comp better compani provid updat outlook
consolid adj oper profit growth anticip y/i
prior outlook y/i growth outlin earli januari lower rang driven larg part
increment invest compani make employe data analyt item
predominantli retail/ltc segment result billion cash benefit compani receiv
chang tax legisl addit compani note would use least half tax
benefit de-lev equiti fell today under-perform
page
page
wolfewolfey/ycurrentresearchactu vs y/ycurrentresearchactu vs quarterquarterestimatey/i estimatedquarterquarterestimatey/i estimatedearn tabl diffearn tabl segment difftot retail pharmaci consolid pharmaci consolid gross interseg segment total ebit consolid retail pharmaci consolid pharmaci interest expens interseg consolid gross incom net incom attribut ex retail pharmaci adj net incom cont op attribut ex pharmaci segment dilut ep attribut ex adj ep cont op attribut ex retail pharmaci pharmaci gener corpor weight average dilut share interseg ebit margin consolid gross sg retail pharmaci store salesebit chang margingross margin retail pharmaci sg gross ebit sg ebit tax margin pharmaci servicesgross sg ebit chang margin retail pharmaci gross sg ebit chang margin pharmaci servicesgross sg ebit interseg eliminationsrevenu combin segment gross profit combin segment gross
